OSRH OSR Health, Inc.
Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1840425 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-50.4%
TTM net income YoY32.8%
TTM EPS YoY68.1%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin24.3%
Operating margin-946.7%
Net margin-599.0%
FCF margin—
EBITDA margin-944.8%
Returns
ROE-10.2%
ROA-5.6%
ROIC (approx.)-12.9%
Asset turnover0.01x
Leverage & solvency
Liabilities / assets24.5%
Debt / equity0.00x
Current ratio0.15x
Interest coverage-34.95x
Cash quality & payout
Operating cash flow / net income0.48x
Accruals ratio-2.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.91M | $3.53M | — | — | — |
| Cost of revenue | $2.31M | $2.72M | — | — | — |
| Gross profit | $592,905 | $811,236 | — | — | — |
| R&D expense | $318,446 | $161,155 | — | — | — |
| SG&A expense | $18.93M | $12.50M | $1.83M | $35,388 | $3,308 |
| Operating income | -$18.34M | -$11.69M | -$1.83M | -$35,388 | -$3,308 |
| Interest expense | $506,196 | $51,335 | — | — | — |
| Pretax income | -$28.89M | -$11.89M | $944,591 | — | — |
| Income tax | -$1.83M | -$1.56M | $540,811 | — | — |
| Net income | -$18.01M | -$2.41M | $403,780 | -$35,388 | -$3,308 |
| EBITDA | -$18.33M | -$11.69M | — | — | — |
| EPS (basic) | -0.92 | -4.79 | 0.05 | -0.01 | 0.00 |
| EPS (diluted) | -0.80 | -4.79 | 0.05 | -0.01 | 0.00 |
| Weighted avg. shares (diluted) | 22.56M | 2.15M | 7.72M | 1.50M | 1.50M |
| Balance sheet | |||||
| Cash & equivalents | $1.70M | $341,543 | $540,207 | $124,501 | $4,757 |
| Receivables | $319,304 | $904,456 | — | — | — |
| Inventory | $196,432 | $922,107 | — | — | — |
| Current assets | $2.82M | $2.33M | $22,627 | $124,501 | $4,757 |
| PP&E, net | $169,130 | $2,334 | — | — | — |
| Goodwill | $24.95M | $24.35M | $27.77M | — | — |
| Intangibles | $142.46M | $148.06M | — | — | — |
| Total assets | $171.24M | $175.24M | $36.63M | $1.23M | $705,087 |
| Current liabilities | $17.17M | $3.46M | $2.04M | $1.26M | $707,207 |
| Short-term debt | $0 | $1.80M | $2.02M | $1.14M | — |
| Long-term debt | $0 | $497,615 | — | — | — |
| Total debt | $0 | $2.30M | — | — | — |
| Total liabilities | $44.20M | $32.03M | $4.11M | $1.26M | $707,207 |
| Shareholders' equity | $77.64M | -$8.33M | -$3.91M | -$37,508 | -$2,120 |
| Net debt | -$1.70M | $1.96M | — | — | — |
| Shares outstanding | 26.60M | 2.15M | 2.15M | 1.73M | 1.73M |
| Cash flow statement | |||||
| Operating cash flow | -$4.33M | -$1.85M | -$818,766 | -$4,235 | -$461 |
| Investing cash flow | -$2.64M | $503,611 | -$33.83M | — | — |
| Financing cash flow | $8.37M | $1.18M | $34.54M | $123,979 | -$57,435 |
| Depreciation & amortization | $7,269 | $5,900 | — | — | — |
| Share buybacks | — | $36.23M | $36.00M | — | — |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.